Eyecare Roadshow 2022
Date: 15/06/2022 (AEST)
Venue: View By Sydney, NSW, 2000
Provider: Luxottica Pty Ltd
Contact: Judy Kwan, [E] judy.kwan@au.luxottica.com, [P] 0456678304
Learning Objectives
- articulate the ANZ strategic business direction for eye care and eye wear
- demonstrate understanding of the importance of booking in the Next Eye Examination (NEE)
- articulate how the NEE will assist with driving enhanced eye care for the patient
- articulate how the Clarifye - WAM800 equipment is different to traditional phoropters
- discuss the equipments that form a part of the Clarifye experience
- identify the importance of prescribing a High Precision (HP) script
- discuss how utilising technology can greatly benefit patient care
- discuss the difference in spectacle lens types
- identify the importance of myopia management for long term patient care
- explain to the patient how myopia management includes various forms of correction
- identify atypical retinal conditions when using technology
- discuss why Optos / Ultra wide field retinal photography is important for patient management and screening
Max CPD hours awarded: 6.75
Session Information
| Name |
|---|
| Essilor Luxottica Retail - POAP 2022 |
| Clinical? |
|---|
| No |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.75 |
| Name |
|---|
| Eyecare Strategy 2022 |
| Clinical? |
|---|
| No |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.5 |
| Name |
|---|
| Great Eyecare Campaign |
| Clinical? |
|---|
| No |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.5 |
| Name |
|---|
| Clarifye & Essilor Vision Centres |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.5 |
| Name |
|---|
| Premium HP Lenses and Stellest |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.5 |
| Name |
|---|
| Instrument Technology |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.5 |
| Name |
|---|
| Optometry & Engagement |
| Clinical? |
|---|
| No |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.5 |
| Name |
|---|
| Myopia Management |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| Yes |
| Duration of CPD Session/Module |
|---|
| 1 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 1.5 |
| Name |
|---|
| Retinal Pathology |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 1 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 1.5 |
| Name | Clinical? | Interactive? | Therapeutic? | CPD Hours |
|---|
| Essilor Luxottica Retail - POAP 2022 | No | Yes | No | 0.25 | 0.75 |
| Eyecare Strategy 2022 | No | Yes | No | 0.25 | 0.5 |
| Great Eyecare Campaign | No | Yes | No | 0.25 | 0.5 |
| Clarifye & Essilor Vision Centres | Yes | Yes | No | 0.25 | 0.5 |
| Premium HP Lenses and Stellest | Yes | Yes | No | 0.25 | 0.5 |
| Instrument Technology | Yes | Yes | No | 0.25 | 0.5 |
| Optometry & Engagement | No | Yes | No | 0.25 | 0.5 |
| Myopia Management | Yes | Yes | Yes | 1 | 1 |
| Retinal Pathology | Yes | Yes | No | 1 | 1 |